Potential effects of age-specific reference ranges for serum prostate-specific antigen

Area of Science:

• Urology
• Oncology
• Biochemistry

Background:

• Serum prostate-specific antigen (PSA) is a key biomarker for prostate cancer detection.
• Current standard reference ranges for PSA may not accurately reflect age-related physiological changes.
• Age-specific reference ranges are proposed to enhance the diagnostic utility of PSA testing.

Purpose of the Study:

• To evaluate the impact of age-specific reference ranges on the interpretation of serum PSA levels.
• To compare the sensitivity and specificity of standard versus age-specific PSA reference ranges in prostate cancer detection.

Main Methods:

• Analysis of serum PSA levels from 10,024 men, grouped by age.
• Comparison of standard (PSA < or = 4.0 ng/ml) and age-specific reference ranges (e.g., < or = 2.5 ng/ml for men < 49 years).
• Review of prostate biopsies and prebiopsy PSA levels for 865 men to calculate diagnostic performance metrics.

Main Results:

• Serum PSA levels showed a significant positive correlation with age (r = 0.33, p < 0.001).
• Age-specific ranges reduced the number of men aged 60+ with elevated PSA (1,373 vs. 1,967, p < 0.001).
• For men aged 70+, age-specific ranges significantly increased specificity (58.6% vs. 34.2%, p < 0.001) but decreased sensitivity (77.6% vs. 91.7%, p < 0.001).

Conclusions:

• Serum PSA levels naturally increase with age, supporting the use of age-specific reference ranges.
• Age-specific PSA ranges enhance specificity but may reduce sensitivity in prostate cancer detection.
• The overall specificity of PSA testing remains limited for definitive prostate cancer diagnosis.